Diploma PLC (FRA:DP9)
Germany flag Germany · Delayed Price · Currency is EUR
62.50
+0.50 (0.81%)
At close: Dec 5, 2025

Revenue by Geography

Fiscal year is October - September.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 2012 - 2020
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2012 - 2020
United Kingdom Revenue
279.80M
Log In
Log In
Log In
Upgrade
Rest of Europe Revenue
247.50M
Log In
Log In
Log In
Upgrade
USA Revenue
802.60M
Log In
Log In
Log In
Upgrade
Rest of World Revenue
194.60M
Log In
Log In
Log In
Upgrade

Revenue

Fiscal year is October - September.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 2012 - 2020
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2012 - 2020
Controls Revenue
833.50M
Log In
Log In
Log In
Upgrade
Seals Revenue
454.30M
Log In
Log In
Log In
Upgrade
Life Sciences Revenue
225.80M
Log In
Log In
Log In
Upgrade

Adjusted EBIT by Geography

Fiscal year is October - September.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 2012 - 2020
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2012 - 2020
United Kingdom Adjusted Operating Profit
8.60M
Log In
Log In
Log In
Upgrade
Rest of Europe Adjusted Operating Profit
48.30M
Log In
Log In
Log In
Upgrade
USA Adjusted Operating Profit
248.50M
Log In
Log In
Log In
Upgrade
Rest of World Adjusted Operating Profit
37.30M
Log In
Log In
Log In
Upgrade

Adjusted EBIT

Fiscal year is October - September.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 2012 - 2020
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2012 - 2020
Controls Adjusted Operating Profit
250.50M
Log In
Log In
Log In
Upgrade
Seals Adjusted Operating Profit
87.80M
Log In
Log In
Log In
Upgrade
Life Sciences Adjusted Operating Profit
44.00M
Log In
Log In
Log In
Upgrade
Corporate Adjusted Operating Profit
-41.30M
Log In
Log In
Log In
Upgrade

EBIT

Fiscal year is October - September.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 2012 - 2020
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2012 - 2020
Controls Operating Profit
211.20M
Log In
Log In
Log In
Upgrade
Seals Operating Profit
79.00M
Log In
Log In
Log In
Upgrade
Life Sciences Operating Profit
34.80M
Log In
Log In
Log In
Upgrade
Corporate Operating Profit
-41.30M
Log In
Log In
Log In
Upgrade

Key Performance Indicators

Fiscal year is October - September.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 2012 - 2020
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 2012 - 2020
Life Sciences Organic Growth
6.00%
Log In
Log In
Log In
Upgrade
Seals Organic Growth
2.00%
Log In
Log In
Log In
Upgrade
Controls Organic Growth
20.00%
Log In
Log In
Log In
Upgrade
Group Organic Growth
11.00%
Log In
Log In
Log In
Upgrade